Sirio Pharma (300791) - Total Liabilities

Latest as of June 2025: CN¥3.07 Billion CNY ≈ $449.47 Million USD

Based on the latest financial reports, Sirio Pharma (300791) has total liabilities worth CN¥3.07 Billion CNY (≈ $449.47 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Sirio Pharma to assess how effectively this company generates cash.

Sirio Pharma - Total Liabilities Trend (2016–2024)

This chart illustrates how Sirio Pharma's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Sirio Pharma's assets to evaluate the company's liquid asset resilience ratio.

Sirio Pharma Competitors by Total Liabilities

The table below lists competitors of Sirio Pharma ranked by their total liabilities.

Company	Country	Total Liabilities
JDM Jingda Mach(Ningbo)Co Ltd SHG:603088	China	CN¥822.81 Million
MilDef Group AB ST:MILDEF	Sweden	Skr1.39 Billion
UNITIL Corporation NYSE:UTL	USA	$1.35 Billion
Cybrid Technologies Inc SHG:603212	China	CN¥1.63 Billion
RHÖN-KLINIKUM Aktiengesellschaft XETRA:RHK	Germany	€523.09 Million
Indian Metals & Ferro Alloys Limited NSE:IMFA	India	Rs8.77 Billion
Anhui Huilong Agricultural Means of Production Co Ltd SHE:002556	China	CN¥7.19 Billion
Cowealth Medical China Co.Ltd. SHG:603122	China	CN¥368.90 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Sirio Pharma's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Sirio Pharma market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.93	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.20	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.54	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sirio Pharma's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sirio Pharma (2016–2024)

The table below shows the annual total liabilities of Sirio Pharma from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥2.84 Billion ≈ $416.29 Million	+8.19%
2023-12-31	CN¥2.63 Billion ≈ $384.79 Million	+77.16%
2022-12-31	CN¥1.48 Billion ≈ $217.20 Million	+16.38%
2021-12-31	CN¥1.28 Billion ≈ $186.62 Million	+173.12%
2020-12-31	CN¥466.95 Million ≈ $68.33 Million	+12.79%
2019-12-31	CN¥414.01 Million ≈ $60.58 Million	-45.49%
2018-12-31	CN¥759.53 Million ≈ $111.14 Million	+7.34%
2017-12-31	CN¥707.58 Million ≈ $103.54 Million	-29.03%
2016-12-31	CN¥997.00 Million ≈ $145.89 Million	--

About Sirio Pharma

SHE:300791 China Packaged Foods

Market Cap

$876.92 Million

CN¥5.99 Billion CNY

Market Cap Rank

#9714 Global

#2726 in China

Share Price

CN¥19.50

Change (1 day)

+0.36%

52-Week Range

CN¥18.79 - CN¥31.81

All Time High

CN¥57.47